Efficacy of proton pump inhibitor in combination with rikkunshito in patients complaining of globus pharyngeus.

Seiichi Nakano, Hidetaka Iwasaki, Eiji Kondo, Katsushi Miyazaki, Haruhiko Shizuku, Seiichiro Kamimura, Junya Fukuda, Ryo Kanamura, N. Takeda
{"title":"Efficacy of proton pump inhibitor in combination with rikkunshito in patients complaining of globus pharyngeus.","authors":"Seiichi Nakano, Hidetaka Iwasaki, Eiji Kondo, Katsushi Miyazaki, Haruhiko Shizuku, Seiichiro Kamimura, Junya Fukuda, Ryo Kanamura, N. Takeda","doi":"10.2152/jmi.63.227","DOIUrl":null,"url":null,"abstract":"OBJECTIVE\nGlobus pharyngeus (GP) is a common symptom of laryngopharyngeal reflux disease (LPRD), and proton pump inhibitor (PPI) and rikkunshito, a traditional Japanese medicine having prokinetic effect improve LPRD symptoms. In the present study, we examined the efficacy of high-dose PPI in combination with rikkunshito in patients complaining of GP.\n\n\nMETHODS\n106 patients complaining of GP without any organic endoscopic findings were enrolled.\n\n\nRESULTS\nPatients were first administrated with high-dose PPI alone for 4 to 8 weeks and the symptom was improved in 65 patients. Among 41 patients with PPI-refractory GP, 22 patients were administrated with high-dose PPI in combination with rikkunshito, and the symptom was improved in 14 of 22 patients 4 weeks later. The average value of a modified reflux symptom index of the responders was similar to that of non-responders. Only a few patients had positive values in reflux finding scores in both groups.\n\n\nCONCLUSION\nThe present findings suggest the existence of a high prevalence of LPRD in patients complaining of GP. The data also suggest that gastroesophageal dysmotility is involved in GP, in addition to excessive acid reflux. The pre-therapeutic laryngopharyngeal symptoms and endoscopic findings could not predict the efficacy of the treatment for GP. J. Med. Invest. 63: 227-229, August, 2016.","PeriodicalId":183570,"journal":{"name":"The journal of medical investigation : JMI","volume":"25 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The journal of medical investigation : JMI","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2152/jmi.63.227","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

OBJECTIVE Globus pharyngeus (GP) is a common symptom of laryngopharyngeal reflux disease (LPRD), and proton pump inhibitor (PPI) and rikkunshito, a traditional Japanese medicine having prokinetic effect improve LPRD symptoms. In the present study, we examined the efficacy of high-dose PPI in combination with rikkunshito in patients complaining of GP. METHODS 106 patients complaining of GP without any organic endoscopic findings were enrolled. RESULTS Patients were first administrated with high-dose PPI alone for 4 to 8 weeks and the symptom was improved in 65 patients. Among 41 patients with PPI-refractory GP, 22 patients were administrated with high-dose PPI in combination with rikkunshito, and the symptom was improved in 14 of 22 patients 4 weeks later. The average value of a modified reflux symptom index of the responders was similar to that of non-responders. Only a few patients had positive values in reflux finding scores in both groups. CONCLUSION The present findings suggest the existence of a high prevalence of LPRD in patients complaining of GP. The data also suggest that gastroesophageal dysmotility is involved in GP, in addition to excessive acid reflux. The pre-therapeutic laryngopharyngeal symptoms and endoscopic findings could not predict the efficacy of the treatment for GP. J. Med. Invest. 63: 227-229, August, 2016.
质子泵抑制剂联合立健脾治疗咽球性麻痹的疗效观察。
目的:咽球病(GP)是喉咽反流病(LPRD)的常见症状,质子泵抑制剂(PPI)和中药利健泻(rikkunshito)具有促动力学作用,可改善LPRD的症状。在本研究中,我们研究了大剂量PPI联合立健泻对主诉GP患者的疗效。方法纳入106例主诉全身性GP患者,无任何器质性内窥镜检查结果。结果65例患者首次单独给予大剂量PPI治疗4 ~ 8周,症状得到改善。在41例PPI难治性GP患者中,22例患者采用大剂量PPI联合立健液治疗,4周后,22例患者中有14例症状得到改善。有反应者的改良反流症状指数的平均值与无反应者相似。在两组中,只有少数患者的反流发现评分为阳性。结论在全科就诊的患者中,LPRD的发生率较高。数据还表明,胃食管运动障碍参与GP,除了过度的胃酸反流。治疗前的咽喉症状和内窥镜检查不能预测GP治疗的疗效。医学杂志,2016年8月,63:227-229。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信